Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al..
Liver Transplantation in European patients with the hepatitis B surface antigen..
N Engl J Med. , 329 (1993), pp. 1842-7
[2]
Lauchart W, Muller R, Pilchlmayr R..
Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts..
Transpl Proc. , 19 (1987), pp. 4051-3
[3]
Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, et al..
Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunisation..
J Hepatol. , 13 (1991), pp. 90-6
[4]
Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al..
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients..
Lancet. , 337 (1991), pp. 813-5
[5]
Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, et al..
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin..
Hepatology. , 24 (1996), pp. 1327-33
[6]
McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, Mc-Cullough CS, Dickson RC, et al..
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization..
Transplantation. , 61 (1996), pp. 1358-64
[7]
Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, Mc-Collough C, et al..
Retransplantation of patients with severe posttransplant hepatitis B in the first allograft..
Transplantation. , 64 (1997), pp. 410-4
[8]
Dodson F, De Vera ME, Bonham CA, Geller DA, Rakela J, Fung JJ..
Lamivudine after hepatitis B immune globuline is effective in preventing hepatitis B recurrence after liver transplantation..
Liver Transpl. , 6 (2000), pp. 434-9
[9]
Naumov NV, Lopes AR, Burra P, Caccamo L, Iemmolo RM, De Man RA, et al..
Randomised trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transpantation..
J Hepatol. , 34 (2001), pp. 888-94
[10]
Buti M, Mas A, Prieto M, Casafont F, González A, Miras M, et al..
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B recurrence after liver transplantation..
J Hepatol. , 38 (2003), pp. 811-7
[11]
Neff GW, OBrien CB, Nery J, Shire N, Montalbano M, Ruiz P, et al..
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade..
Liver Tranpl. , 10 (2004), pp. 1372-8
[12]
Wong S, Chu C, Wai C, Howell T, Moore C, Fontana RJ, et al..
Low Risk of hepatitis B vurus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy..
Liver Transpl. , 13 (2007), pp. 374-81
[13]
Sánchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, et al..
Hepatitis B immunoglobulin discontinuation followed by hepatitis B vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation..
Hepatology. , 31 (2000), pp. 496-501
[14]
Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, et al..
Failure of reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis..
Hepatology. , 35 (2002), pp. 176-81
[15]
Bienzle U, Gunther M, Neuhaus R, Vandepapeliere P, Vollmar J, Lun A, et al..
Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease..
Hepatology. , 38 (2003), pp. 811-9
[16]
Fung SK, Chae HB, Fontana RJ, Conjeevaran H, Marrero J, Oberhelman K, et al..
Virologic response and resístanse to adefovir in patients with chronic hepatitis B..
J Hepatol. , 44 (2006), pp. 283-90
[17]
Snow A, Thibault V, Qi X..
Combination of adefovir (ADV) and lamivudine (LAM) prevented emergence of adefovir resistance mutations in chronic hepatitis B patients with lamivudineresistant HBV..
Gastroenterology. , 128 (2005), pp. M945
[18]
Lo CM, Li CL, Lau GK, Chan SC, Ng IO, Fan ST..
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutants using add-on asdefovir dipivoxil plus lamivudine..
Liver Transpl. , 11 (2005), pp. 807-13
[19]
Schiff E, Lai C, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, et al..
Adefovir Dipivoxil for Wait-Listed and Post-Liver Transplantation Patients With Lamivudine-Resistant Hepatitis B: Final Long-Term Results..
Liver Transpl. , 13 (2007), pp. 349-60
